Home
blog

Singapore startup Signsbeat tests whether wearable signals map to metabolic stability

Singapore startup Signsbeat is testing whether wearable-derived signals (SB Score) correlate with CGM-measured glycaemic variability in a ~50-person, 14-day observational study with the University of Nottingham Malaysia; initial results are expected later this year.

28 May 2026

SOND exits stealth with $7M and debuts Dreambuds, a closed-loop sleep earbud

SOND, founded by Bose’s former Head of Sleep Yadid Ayzenberg, left stealth with $7M and launched Dreambuds, an in-ear closed-loop sleep system that tracks 12 physiologic signals and uses a cloud AI coach. The company plans mass production in Q2 2026 after a crowdfunding push and is taking reservations now.

28 May 2026

Adam Vareberg develops wireless scalp stimulators at UW–Madison

Adam Vareberg, a Harvard S.B. ’19 and Ph.D. student at UW–Madison’s Aviad Hai Lab, is developing wireless scalp stimulators designed to target brain regions without the implanted leads used in conventional deep brain stimulation.

27 May 2026

The innovation that helped a ballerina with degenerative disease dance again

Dentsu Lab and NTT used a non-invasive EEG headset and machine learning to let Breanna Olson with ALS control a digital avatar and perform live in mixed reality in Amsterdam last December. The work, part of Project Humanity, remains a non-commercial prototype the teams are continuing to train with other users.

26 May 2026

MintNeuro signs multi‑year supply deal with Motif Neurotech and markets platform at global meetings

MintNeuro agreed a multi‑year supply deal with Motif Neurotech to provide neural sensing and stimulation chips for Motif's DOT implant, which has FDA clearance to begin a clinical trial in treatment‑resistant depression. The company also promoted its platform this week at the International Neuromodulation Society congress and Deep Tech Momentum 2026.

25 May 2026

KGMU and IIT Kanpur secure patent for ear-worn vagus nerve stimulator aimed at anxiety and panic

KGMU and IIT Kanpur won a utility patent under the SIB SHInE programme for an ear-worn vagus nerve stimulator aimed at reducing anxiety and managing panic attacks. The device is the third utility patent from SIB SHInE; further patent applications are under examination.

25 May 2026

Kordata launches to bring neural recording tech into clinical trial sites

Kordata Dynamics launched from BIOS Health to add neural recording and real‑time dosing tools to hospital trial sites. BIOS retains majority ownership and Emil Hewage will lead the spinout, which targets CNS trials in Alzheimer’s, Parkinson’s and epilepsy.

23 May 2026

Magnetoelectric Backscatter System Improves Wireless Links for Bioelectronic Implants

A 2026 Communications Engineering paper by Alrashdan et al. reports a magnetoelectric backscatter link that reduces implant power use and sustains data transmission through tissue in ex vivo and phantom tests, with ranges from millimetres to several centimetres.

14 May 2026

CorTec's Brain Interchange Accepted into FDA TAP; Third U.S. Patient Implanted

CorTec's Brain Interchange™ has been accepted into the FDA's Total Product Life Cycle Advisory Program and received Breakthrough Device Designation; the company reported a third patient implant in the NIH‑funded U.S. clinical study and nine months of stable device operation in the first U.S. participant.

25 Apr 2026

Report: Lucid-dreaming devices market to reach $201.8M by 2033; North America holds 40%

DataM Intelligence projects the lucid-dreaming devices market will grow from $113.1M in 2023 to $201.8M by 2033, with North America holding a 40% share. The report highlights REM-detection and EEG wearables, recent product updates from iWinks and Dreem, and gaps in clinical validation.

25 Apr 2026

A “muddy intervention”: taVNS yields mixed outcomes for people with Long COVID

People with Long COVID are trying ear-based vagus nerve stimulation at home with mixed outcomes. Small trials, a 2024 survey and ongoing studies show both benefit for some users and reports of crashes and adverse effects; experts advise caution and physician oversight.

23 Apr 2026

Medtronic launches Adaptive Deep Brain Stimulation system in India

Medtronic has introduced its Adaptive Deep Brain Stimulation (aDBS) system in India, using US FDA‑approved BrainSense sensing to adjust stimulation in real time for Parkinson’s patients. The company says the device aims to improve symptom control and extend battery life amid a rising Parkinson’s burden in India.

23 Apr 2026

Trump signs order to speed review of psychedelics, including ibogaine

President Trump has signed an order to accelerate federal review of psychedelic drugs, including ibogaine, a substance backed by some veterans but linked to dangerous heart risks.

20 Apr 2026

brainjo raises €2M to advance VR adjunct for pediatric ADHD therapy

Regensburg startup brainjo raised €2 million in a seed round led by HTGF to fund clinical trials and regulatory work for a VR-based DiGA aimed at children with ADHD, developed with MEDICE Health Family and targeting approval in 2028.

20 Apr 2026

FDA clears Cala kIQ Plus wearable for Parkinson’s hand tremor

The FDA has cleared Cala Health’s Cala kIQ Plus, a wrist‑worn TAPS neurostimulation device for hand tremor in Parkinson’s and essential tremor; company data from 78 patients will be presented at AAN 2026.

19 Apr 2026

Mobia Medical markets Vivistim paired VNS system for chronic ischemic stroke

Mobia Medical markets the FDA-approved Vivistim Paired VNS System, an implanted vagus nerve stimulator the company says improves upper-limb function in chronic ischemic stroke survivors. The firm describes the device as delivering stimulation paired with movement to promote neuroplasticity.